The Alliance for Regenerative Medicine Appoints Rita Johnson-Greene as Chief Operating Officer
March 21, 2023 12:02 ET
|
Alliance For Regenerative Medicine
Washington, D.C., March 21, 2023 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the engineered cell therapy and...
The Alliance for Regenerative Medicine Appoints Mark Battaglini as Chief Strategy Officer
January 03, 2023 16:00 ET
|
Alliance For Regenerative Medicine
Washington, D.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the cell and gene therapy sector,...
The Alliance for Regenerative Medicine Announces Election of 2023 Officers, Executive Committee, and Board of Directors
October 11, 2022 11:00 ET
|
Alliance For Regenerative Medicine
Carlsbad, CA, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise of regenerative...
The Alliance for Regenerative Medicine Announces the Appointment of Timothy D. Hunt as Chief Executive Officer
August 10, 2022 14:14 ET
|
Alliance For Regenerative Medicine
Washington, D.C., Aug. 10, 2022 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the cell and gene therapy sector, today...
ARM and NIIMBL Release Project A-Cell To Bring Quality By Design Principles To Cell-Based Therapy Manufacturing
July 26, 2022 11:08 ET
|
Alliance For Regenerative Medicine
Washington, DC, July 26, 2022 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing BioPharmaceuticals (NIIMBL) today released...
Alliance for Regenerative Medicine Announces CEO Transition
April 27, 2022 09:00 ET
|
Alliance For Regenerative Medicine
Washington, DC, April 27, 2022 (GLOBE NEWSWIRE) -- Janet Lynch Lambert will step down as the CEO of the Alliance for Regenerative Medicine after guiding the leading international advocacy...
Cell and Gene Therapies Poised to Disrupt Health Care Status Quo With Wave of New Treatments
March 31, 2022 09:00 ET
|
Alliance For Regenerative Medicine
Washington, DC, March 31, 2022 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine, the leading international advocacy organization dedicated to realizing the promise of regenerative...
The Alliance for Regenerative Medicine Announces Election of 2022 Officers, Executive Committee, and Board of Directors
October 21, 2021 09:00 ET
|
Alliance for Regenerative Medicine
Washington, DC, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise...
Global Cell & Gene Therapy Sector on Pace for Annual Records in Product Approvals and Financings, Says Alliance for Regenerative Medicine
August 18, 2021 09:42 ET
|
Alliance for Regenerative Medicine
ARM’s H1 2021 Report Chronicles ‘A Year of Firsts’ For The Regenerative Medicine Sector Washington, DC, Aug. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The regenerative medicine and...
Alliance for Regenerative Medicine Annual Report Highlights Record Sector Growth and Resilience in 2020
March 16, 2021 10:43 ET
|
Alliance for Regenerative Medicine
Sector financing reached $19.9B in 2020, doubling from the previous year; 2021 is likely to be a record year for the number of regulatory decisions on new regenerative medicine products Washington,...